AMERICAN INTERNATIONAL GROUP, INC. - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 225 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.6%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$1,507,204
-91.0%
57,156
-94.2%
0.01%
-90.3%
Q2 2023$16,818,367
-62.5%
977,812
-63.8%
0.10%
-65.0%
Q1 2023$44,838,521
+58.2%
2,704,374
-27.3%
0.29%
+48.5%
Q4 2022$28,347,048
-23.3%
3,720,085
+0.0%
0.20%
-26.4%
Q3 2022$36,974,000
+9.5%
3,719,666
+0.0%
0.27%
+18.0%
Q2 2022$33,769,000
-10.6%
3,718,964
-0.1%
0.23%
+10.1%
Q1 2022$37,786,000
-39.2%
3,722,680
-0.1%
0.21%
-33.4%
Q4 2021$62,157,000
-64.4%
3,726,388
-0.1%
0.31%
-66.6%
Q3 2021$174,774,000
-23.1%
3,728,904
-0.0%
0.93%
+21.0%
Q2 2021$227,399,000
-0.9%
3,730,302
+0.1%
0.77%
-4.3%
Q1 2021$229,450,000
-3.5%
3,724,834
+11.4%
0.80%
-8.6%
Q4 2020$237,673,000
+29.5%
3,342,334
-40.5%
0.88%
+0.1%
Q3 2020$183,480,000
+0.1%
5,619,928
-0.0%
0.88%
-0.5%
Q2 2020$183,298,000
+6.8%
5,620,919
-5.0%
0.88%
-6.0%
Q1 2020$171,658,000
-27.4%
5,919,246
-12.2%
0.94%
+3.0%
Q4 2019$236,391,000
+63.2%
6,744,392
-0.0%
0.91%
+56.3%
Q3 2019$144,847,000
-20.2%
6,746,511
+0.2%
0.58%
-17.6%
Q2 2019$181,569,0006,732,2440.71%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$100,609,51348.41%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$514,990,89915.50%
M28 Capital Management LP 304,700$5,051,9265.71%
Cormorant Asset Management, LP 4,557,414$75,5624.98%
Octagon Capital Advisors LP 1,338,160$22,186,6933.19%
Ikarian Capital, LLC 594,686$9,859,8942.24%
Affinity Asset Advisors, LLC 389,800$6,462,8842.13%
VIKING GLOBAL INVESTORS LP 26,620,991$441,376,0312.07%
Ikarian Capital, LLC 549,600$9,112,3682.07%
Affinity Asset Advisors, LLC 320,000$5,305,6001.75%
View complete list of BRIDGEBIO PHARMA INC shareholders